Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen (Q37634052)

21 August 2017

Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen (English)

1 reference

21 August 2017

0 references

0 references

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

Neil L Berinstein

1

1 reference

21 August 2017

Gregory T Wolf

2

1 reference

21 August 2017

Paul H Naylor

3

1 reference

21 August 2017

Lorraine Baltzer

4

1 reference

21 August 2017

James E Egan

5

1 reference

21 August 2017

Harvey J Brandwein

6

1 reference

21 August 2017

Theresa L Whiteside

7

1 reference

21 August 2017

Lynn C Goldstein

8

1 reference

21 August 2017

Adel El-Naggar

9

1 reference

21 August 2017

Cecile Badoual

10

1 reference

21 August 2017

Wolf-Herve Fridman

11

1 reference

21 August 2017

J Michael White

12

1 reference

21 August 2017

John W Hadden

13

1 reference

21 August 2017

language of work or name

1 reference

6 November 2011

1 reference

Cancer Immunology, Immunotherapy

21 August 2017

1 reference

21 August 2017

61

1 reference

21 August 2017

771-782

1 reference

21 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-011-1134-z

21 August 2017

0 references

cites work

Immune suppression in head and neck cancers: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Zinc in cancer prevention

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Mononuclear phagocytes in head and neck squamous cell carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Immunotherapy in head and neck cancer: current practice and future possibilities

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Anti-tumor vaccines in head and neck cancer: targeting immune responses to the tumor

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Protective mechanisms of head and neck squamous cell carcinomas from immune assault

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Immunobiology of head and neck cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Dendritic cells and HNSCC: a potential treatment option? (Review).

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Role of tumour-associated macrophages in cancer-related inflammation

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

A phase 1 safety study of an IRX-2 regimen in patients with squamous cell carcinoma of the head and neck

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Increased prevalence of interleukin-17-producing CD4(+) tumor infiltrating lymphocytes in human oral squamous cell carcinoma.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

IRX-2 increases the T cell-specific immune response to protein/peptide vaccines

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5300054

Deficient immunity in head and neck cancer due to excessive monocyte production of prostaglandins

3 December 2018

1 reference

12 December 2020

Augmentation of the human immune response by cyclophosphamide

1 reference

12 December 2020

Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphatically

1 reference

12 December 2020

The immunopharmacology of head and neck cancer: an update

1 reference

12 December 2020

Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer

1 reference

12 December 2020

Interleukins and contrasuppression induce immune regression of head and neck cancer

1 reference

12 December 2020

IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro

1 reference

12 December 2020

Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis

1 reference

12 December 2020

The treatment of zinc deficiency is an immunotherapy

1 reference

12 December 2020

Histologic findings in patients with head and neck squamous cell carcinoma receiving perilymphatic natural cytokine mixture (IRX-2) prior to surgery

1 reference

12 December 2020

Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2

1 reference

12 December 2020

T-cell markers in tumor-infiltrating lymphocytes of head and neck cancer

1 reference

12 December 2020

10.1007/S00262-011-1134-Z

Identifiers

DOI

1 reference

21 August 2017

1 reference

21 August 2017

1 reference